New cholesterol drug tested right after heart attacks to stop second attacks
NCT ID NCT07142265
First seen Jan 04, 2026 · Last updated May 24, 2026 · Updated 19 times
Summary
This study tests whether giving the cholesterol-lowering drug inclisiran soon after a heart attack can reduce the risk of another heart attack, stroke, or related hospital stay. About 300 adults in Russia who had a heart attack and have high cholesterol will receive inclisiran early and be followed for 12 months. Researchers will track heart events, cholesterol levels, and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGCheboksary, 428000, Russia
-
Novartis Investigative Site
RECRUITINGGrozny, 364051, Russia
-
Novartis Investigative Site
RECRUITINGKemerovo, 650002, Russia
-
Novartis Investigative Site
RECRUITINGKhanty-Mansiysk, 628012, Russia
-
Novartis Investigative Site
RECRUITINGMoscow, 105203, Russia
-
Novartis Investigative Site
RECRUITINGMoscow, 119607, Russia
-
Novartis Investigative Site
RECRUITINGMoscow, 121552, Russia
-
Novartis Investigative Site
RECRUITINGNovosibirsk, 630051, Russia
-
Novartis Investigative Site
RECRUITINGPenza, 440026, Russia
-
Novartis Investigative Site
RECRUITINGPetrozavodsk, 185019, Russia
-
Novartis Investigative Site
RECRUITINGRostov-on-Don, 344010, Russia
-
Novartis Investigative Site
RECRUITINGS Petersburg, 192242, Russia
-
Novartis Investigative Site
RECRUITINGSamara, 443070, Russia
-
Novartis Investigative Site
RECRUITINGSyktyvkar, 167981, Russia
-
Novartis Investigative Site
RECRUITINGTomsk, 634009, Russia
-
Novartis Investigative Site
RECRUITINGUlan-Ude, 670031, Russia
Conditions
Explore the condition pages connected to this study.